[Inactivation of carcinomatous Krebs 2 cell by immune serums of nuclear antigens].
D000818:Animals; D000974:Antibodies, Antinuclear / Q000494:pharmacology*; D000937:Antigen-Antibody Reactions; D000941:Antigens / Q000008:administration & dosage; D002287:Carcinoma, Krebs 2 / Q000276:immunology* / Q000517:prevention & control; D055598:Chemical Phenomena; D002621:Chemistry; D003165:Complement System Proteins / Q000494:pharmacology; D006386:Hemagglutination Tests; D007106:Immune Sera / Q000494:pharmacology*; D005779:Immunodiffusion; D011817:Rabbits; D051381:Rats
D000974:Antibodies, Antinuclear; D000941:Antigens; D007106:Immune Sera; D003165:Complement System Proteins
Inactivation de la cellule carcinomateuse Krebs 2 pa4 des immunsérums d'antigènes nucléaires.